R-Tech Ueno, Ltd. clinical trials
Acquired by Keenova Therapeutics plc, Feb 13, 2018 · source ↗
The registry lists 2 studies whose lead sponsor is R-Tech Ueno, Ltd.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 11, 2019.
Before and after it joined Keenova Therapeutics plc
- First submitted before R-Tech Ueno, Ltd. became part of Keenova Therapeutics plc
- 2
- First submitted after R-Tech Ueno, Ltd. became part of Keenova Therapeutics plc
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- R-Tech Ueno, Ltd.2 studies
Something wrong with this grouping? Tell us on the Keenova Therapeutics plc page.
Studies
Recruiting first, then most recently updated. Showing 2 of 2. All Keenova Therapeutics plc studies →
- A Phase 1/2, RU-101 Ophthalmic Solution in Patients With Severe Dry EyeCompletedNCT01843894Phase 1/2
Sponsor listed in the registry: R-Tech Ueno, Ltd. · First submitted before R-Tech Ueno, Ltd. became part of Keenova Therapeutics plc
- Phase III Efficacy and Safety Clinical Study of UF-021 for Treatment of Retinitis PigmentosaTerminatedNCT01786395Phase 3
Sponsor listed in the registry: R-Tech Ueno, Ltd. · First submitted before R-Tech Ueno, Ltd. became part of Keenova Therapeutics plc